Composition and method for reducing neutropenia
US11229642B2 · kind B2 · utility
2Cited by
48References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2017 |
| Grant date | Jan 25, 2022 |
| Priority date | — |
| Expiry date | Sep 14, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are methods of reducing neutropenia that is caused by chemotherapy or radiation therapy by administering plinabulin to a subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.